AKBA
$7.07
Akebia Therapeutics
$.40
6.00%
AKBA
Earnings Whisper ®
N/A
1st Quarter March 2020
Consensus:  ($0.63)
Revenue:  $77.54 Mil
Tuesday
Jun 9
7:50 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when AKBA reports earnings?
Beat
Meet
Miss

Where is AKBA's stock price going from here?
Up
Flat
Down
Stock chart of AKBA
Analysts
Summary of analysts' recommendations for AKBA
Score
Grade
Pivots
Resistance
$8.08
$7.77
$7.22

$6.91

Support
$6.36
$6.05
$5.50
Tweet
Growth
Peers
BioMarin PharmaceuticalRegeneron PharmaceuticalsVertex PharmaceuticalsJohnson & JohnsonInterCeptZoetisBristol-Myers SquibbMylanUltragenyx PharmaceuticalAlkermes